View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 11/20/2024

Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/11/2024

Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...

Bayer AG: 1 director

A director at Bayer AG bought 11,278 shares at 20.745EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Michael B. Schäfer ... (+2)
  • Michael B. Schäfer
  • Stephan Wulf

Bayer : Weaker-than-expected Q3 results and cut in group’s adj. EBITDA...

>Group’s adj. EBITDA significantly below expectations - At a group level, Bayer’s Q3 sales of € 9.97bn (-3.6%), were below our (€ 10.2bn) and consensus estimates (€ 10.1bn), the group’s EBITDA of € 1,251m (-26%) came in 9% weaker than we expected (€ 1,376m) and was 5% below the consensus (€ 1,313m). The significant group’s EBITDA decline vs Q3 2023 was driven by the Pharma division, which came in at € 1,102m (23.4% below Q3 2023). Adjusted EPS of € 0.24 was 37% below ...

Rafael Bonardell
  • Rafael Bonardell

BAYER: RDOS. 3T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'24 vs 3T'23: Ventas: 9.968 M euros (-3,6% vs -1,7% BS(e) y -2,2% consenso); EBITDA: 1.251 M euros (-25,8% vs -18,0% BS(e) y -22,1% consenso). Rdos. 9meses'24 vs 9meses'23: Ventas: 34.877 M euros (-2,5% vs -2,0% BS(e) y -2,1% consenso); EBITDA: 7.774 M euros (-10,5% vs -9,0% BS(e) y -9,8% consenso).

Research Department
  • Research Department

INFORME DIARIO 12 NOVIEMBRE + RDOS. ESPAÑA Y EUROPA 3T’24. IDEAS DESTA...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: BANKINTER, CAIXABANK, MINOR HOTELS, SECTOR INMOBILIARIO, SECTOR SEGUROS. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. Los mercados se estabilizan En una jornada de pocos catalizadores las bolsas europeas rebotaron, compensand...

Carole Braudeau
  • Carole Braudeau
AC ACCOR SA
DG VINCI SA ... (+16)

Credit Morning 10/25/2024

Ontex: Q3 24 call notes: “Actively” looking at refinancing… but no further specificationOrano: announcement of a € 300m capital increase and suspension of activities in NigerArdagh: another significant PW in glassNexity: Q3 at last encouraging with positive signals and a new divestment announcedValeo revises its 2024 guidance and suspends its 2025 objectives in the face of an increasingly difficult environment>...

Carole Braudeau
  • Carole Braudeau
AC ACCOR SA
DG VINCI SA ... (+16)

Morning Crédit 25/10/2024

Ontex : Q3 24 call notes: “Actively” looking at refinancing… but no further specificationOrano : annonce d’une augmentation de capital de 300 m EUR et de la suspension des activités au NigerArdagh : encore un PW significatif dans le verreNexity : un T3 enfin encourageant avec des signaux positifs et une nouvelle cession annoncéeValeo révise sa guidance 2024 et suspend ses objectifs 2025 face à un environnement de plus en plus difficile>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 10/14/2024

Fitch revises France's outlook to negative>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 14/10/2024

Fitch place la note AA- de la France sous perspective négative>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 10/10/2024

United Group prices € 750m of new 7NC3 secured notes at a yield of 6.5% Cirsa: imminent IPO?Reportedly one third of ZF’s German production footprint at risk PCB case surprisingly reviewed by Washington State Supreme Court>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 10/10/2024

United Group émet 750 m EUR de nouvelles obligations secured 7NC3 avec un rendement de 6.5% Cirsa : IPO imminente ?Reportedly one third of ZF’s German production footprint at risk Bayer: PCB case surprisingly reviewed by Washington State Supreme Court>...

Bayer AG: Update to credit analysis

Our credit view of Bayer AG reflects its excellent liquidity profile, constrained by uncertainty surrounding a conclusive settlement of ongoing RoundUp/glyphosate litigation.

Bayer AG: Key facts and statistics - LTM June 2024

A summary company profile, detailing Bayer AG’s business operations and financial highlights.

Bayer AG - June 2024 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Research Department
  • Research Department

INFORME DIARIO 12 SEPTIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AEDAS, CAF, CAMBIOS IBEX 35, NEINOR. EUROPA: BAYER, UNICREDIT. El Ibex roza los 11.300 puntos Jornada positiva en Europa, con un dato de inflación en EE.UU. que no ofreció sorpresas y donde el Ibex lideró los avances tras los buenos resultados de Inditex. Así, en el STOXX 600 Retail (impulsado por los resultados de Inditex) y Tecnología presentaron las mayores ganancias mientras que Inmobiliario (el segundo mejor sector en los últimos 3 meses) y B. ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch